Viatris VTRS
NASDAQ VTRS
$17.59 +0.14 (+0.77%)
As of: Oct 2, 2026 · 10:10 AM EDT

Viatris (VTRS) Non Operating Interest Expenses (2020 - 2026)

Updated

Viatris' Non Operating Interest Expenses came in at $120.7 million for Q2 2026, up 3.5% from $116.6 million a year earlier and up 0.5% from the prior quarter.

Analysis

Viatris (VTRS) Non Operating Interest Expenses (2020 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Viatris reported Non Operating Interest Expenses of $480 million, down 3.6% year-over-year; for FY2025, it was $471.3 million, down 14.3% from FY2024.

  • Non Operating Interest Expenses has declined in each of the last four years, with a five-year compound annual growth rate of -1.1% (FY2020 to FY2025).
  • Going back by year, Non Operating Interest Expenses was $550 million in FY2024 (-4.0%), $573.1 million in FY2023 (-3.3%), $592.4 million in FY2022 (-6.9%) and $636.2 million in FY2021 (+27.8%).
  • The Q2 2026 figure represents the highest quarterly Non Operating Interest Expenses since Q3 2024.
  • Year-over-year, Non Operating Interest Expenses increased in three of the last eight quarters, with an average decline of 7.4%.
  • The fastest year-over-year change in Non Operating Interest Expenses over five years came in Q1 2026 (growth of 4.0%), and the weakest in Q2 2025 (a decline of 20.0%).
  • Business Quant data shows VTRS's Non Operating Interest Expenses at $120.1 million (Q1 2026), $119.6 million (Q4 2025) and $119.6 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Operating Interest Expenses (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 281.00 Mn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -462.00 Mn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -435.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 673.00 Mn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 247.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Viatris 20.35 Bn 15.36 Bn 1.46 Bn 120.70 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 120.70 Mn
Mar 31, 2026 120.10 Mn
Dec 31, 2025 119.60 Mn
Sep 30, 2025 119.60 Mn
Jun 30, 2025 116.60 Mn
Mar 31, 2025 115.50 Mn
Dec 31, 2024 120.20 Mn
Sep 30, 2024 145.60 Mn
Jun 30, 2024 145.80 Mn
Mar 31, 2024 138.40 Mn
Dec 31, 2023 140.90 Mn
Sep 30, 2023 141.50 Mn
Jun 30, 2023 143.70 Mn
Mar 31, 2023 147.00 Mn
Dec 31, 2022 147.10 Mn
Sep 30, 2022 153.20 Mn
Jun 30, 2022 145.90 Mn
Mar 31, 2022 146.20 Mn
Dec 31, 2021 148.20 Mn
Sep 30, 2021 151.90 Mn
API Access

Viatris Non Operating Interest Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=VTRS&period=max&api_key=YOUR_API_KEY